These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 34952732)

  • 1. [Effectiveness of BNT162b2 vaccine to preventing COVID-19 in healthcare personnel].
    Chico-Sánchez P; Gras-Valentí P; Algado-Sellés N; Merino-Lucas E; Rodríguez-Díaz JC; Ronda-Pérez E; Sánchez-Payá J;
    Gac Sanit; 2022; 36(5):484-487. PubMed ID: 34952732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effectiveness of the first dose of BNT162b2 vaccine to preventing covid-19 in healthcare personnel.].
    Gras-Valentí P; Chico-Sánchez P; Algado-Sellés N; Jiménez-Sepúlveda NJ; Gómez-Sotero IL; Fuster-Pérez M; Cartagena-Llopis L; Sánchez-Valero M; Cerezo-Milán P; Martínez-Tornero I; Tremiño-Sánchez L; Nadal-Morante V; Monerris-Palmer M; Esclapez-Martínez A; MorenodeArcos-Fuentes E; Escalada-Martín I; Escribano-Cañadas I; Merino-Lucas E; Rodríguez-Díaz JC; Sánchez-Payá J
    Rev Esp Salud Publica; 2021 Apr; 95():. PubMed ID: 33913444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effectiveness of mRNA vaccines to prevent SARS-CoV-2 infection and hospitalisation for COVID-19 according to the time elapsed since their administration in health professionals in the Valencian Autonomous Community (Spain).
    Chico-Sánchez P; Gras-Valentí P; Algado-Sellés N; Jiménez-Sepúlveda N; Vanaclocha H; Peiró S; Burgos JS; Berenguer A; Navarro D; Sánchez-Payá J;
    Prev Med; 2022 Oct; 163():107237. PubMed ID: 36057393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Waning of BNT162b2 Vaccine Effectiveness for SARS-CoV-2 Infection Prevention over Time: A Test-Negative Study in Health Care Professionals of a Health Department from January 2021 to December 2021.
    Jiménez-Sepúlveda N; Chico-Sánchez P; Castro-García JM; Escribano-Cañadas I; Merino-Lucas E; Ronda-Pérez E; Sánchez-Payá J; Gras-Valentí P; On Behalf Of The Covid-Preventive Medicine Group
    Int J Environ Res Public Health; 2022 Oct; 19(21):. PubMed ID: 36360764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early effectiveness of BNT162b2 Covid-19 vaccine in preventing SARS-CoV-2 infection in healthcare personnel in six Israeli hospitals (CoVEHPI).
    Katz MA; Harlev EB; Chazan B; Chowers M; Greenberg D; Peretz A; Tshori S; Levy J; Yacobi M; Hirsch A; Amichay D; Weinberger R; Dor AB; Taraday EK; Reznik D; Chayat CB; Sagas D; Zvi HB; Berdinstein R; Rashid G; Avni YS; Mandelboim M; Zuckerman N; Rainy N; Akriv A; Dagan N; Kepten E; Barda N; Balicer RD
    Vaccine; 2022 Jan; 40(3):512-520. PubMed ID: 34903372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity and effectiveness of BNT162b2 COVID-19 vaccine in a cohort of healthcare workers in Milan (Lombardy Region, Northern Italy).
    Consonni D; Lombardi A; Mangioni D; Bono P; Oggioni M; Uceda Renteria S; Valzano A; Bordini L; Nava CD; Tiwana N; Gentiloni Silverj F; Castaldi S; Rognoni M; Cavalieri D'Oro L; Carugno M; Luisetti G; Riboldi L; Ceriotti F; Bandera A; Gori A; Pesatori AC
    Epidemiol Prev; 2022; 46(4):250-258. PubMed ID: 36259341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of BNT162b2 Vaccine Effectiveness in Galicia, Northwest Spain.
    Pardo-Seco J; Mallah N; López-Pérez LR; González-Pérez JM; Rosón B; Otero-Barrós MT; Durán-Parrondo C; Rodríguez-Tenreiro C; Rivero-Calle I; Gómez-Carballa A; Salas A; Martinón-Torres F
    Int J Environ Res Public Health; 2022 Mar; 19(7):. PubMed ID: 35409724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of homologous and heterologous booster doses for an inactivated SARS-CoV-2 vaccine: a large-scale prospective cohort study.
    Jara A; Undurraga EA; Zubizarreta JR; González C; Pizarro A; Acevedo J; Leo K; Paredes F; Bralic T; Vergara V; Mosso M; Leon F; Parot I; Leighton P; Suárez P; Rios JC; García-Escorza H; Araos R
    Lancet Glob Health; 2022 Jun; 10(6):e798-e806. PubMed ID: 35472300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-world effectiveness of BNT162b2 vaccine against SARS-CoV-2 infection among adolescents (12 to 17-year-olds) in Malaysia.
    Husin M; Tok PSK; Suah JL; Thevananthan T; Tng BH; Peariasamy KM; Sivasampu S
    Int J Infect Dis; 2022 Aug; 121():55-57. PubMed ID: 35500793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of mRNA BNT162b2 COVID-19 vaccine against SARS-CoV-2 Delta variant among elderly residents from a long-term care facility, South of France, May 2021.
    Sánchez Ruiz MA; Adonias G; Robaglia-Schlupp A; Rapilly F; Chabert M; Ramalli L; Reilhes O; Bruel C; Malfait P; Chaud P
    Eur Rev Med Pharmacol Sci; 2022 Apr; 26(7):2586-2591. PubMed ID: 35442474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in COVID-19 Vaccine Administration and Effectiveness Through October 2021.
    Winkelman TNA; Rai NK; Bodurtha PJ; Chamberlain AM; DeSilva M; Jeruzal J; Johnson SG; Kharbanda A; Klyn N; Mink PJ; Muscoplat M; Waring S; Yu Y; Drawz PE
    JAMA Netw Open; 2022 Mar; 5(3):e225018. PubMed ID: 35357452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association Between Vaccination With BNT162b2 and Incidence of Symptomatic and Asymptomatic SARS-CoV-2 Infections Among Health Care Workers.
    Angel Y; Spitzer A; Henig O; Saiag E; Sprecher E; Padova H; Ben-Ami R
    JAMA; 2021 Jun; 325(24):2457-2465. PubMed ID: 33956048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of Booster and Influenza Vaccines against COVID-19 among Healthcare Workers, Taiwan.
    Sim JY; Wu PS; Cheng CF; Chao YC; Yu CH
    Emerg Infect Dis; 2022 Oct; 28(10):2126-2130. PubMed ID: 36037810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of the BNT162b2 mRNA Covid-19 vaccine in Spanish healthcare workers.
    Núñez López C; González de Abreu JM; Pérez-Blanco V; de Miguel Buckley R; Romero Gómez MP; Díaz-Menéndez M; ;
    Enferm Infecc Microbiol Clin (Engl Ed); 2023 Jan; 41(1):33-35. PubMed ID: 36621246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 vaccine effectiveness among healthcare workers in Albania (COVE-AL): protocol for a prospective cohort study and cohort baseline data.
    Sridhar S; Fico A; Preza I; Hatibi I; Sulo J; Kissling E; Daja R; Ibrahim R; Lemos D; Rubin-Smith J; Schmid A; Vasili A; Valenciano M; Jorgensen P; Pebody R; Lafond KE; Katz MA; Bino S
    BMJ Open; 2022 Mar; 12(3):e057741. PubMed ID: 35321895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of a Third Dose of BNT162b2 Vaccine With Incidence of SARS-CoV-2 Infection Among Health Care Workers in Israel.
    Spitzer A; Angel Y; Marudi O; Zeltser D; Saiag E; Goldshmidt H; Goldiner I; Stark M; Halutz O; Gamzu R; Slobodkin M; Amrami N; Feigin E; Elbaz M; Furman M; Bronstein Y; Chikly A; Eshkol A; Furer V; Mayer T; Meijer S; Melloul A; Mizrahi M; Yakubovsky M; Rosenberg D; Safir A; Spitzer L; Taleb E; Elkayam O; Silberman A; Eviatar T; Elalouf O; Levinson T; Pozyuchenko K; Itzhaki-Alfia A; Sprecher E; Ben-Ami R; Henig O
    JAMA; 2022 Jan; 327(4):341-349. PubMed ID: 35006256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Waning COVID-19 Vaccine Effectiveness for BNT162b2 and CoronaVac in Malaysia: An Observational Study.
    Suah JL; Husin M; Tok PSK; Tng BH; Thevananthan T; Low EV; Appannan MR; Muhamad Zin F; Mohd Zin S; Yahaya H; Peariasamy KM; Sivasampu S
    Int J Infect Dis; 2022 Jun; 119():69-76. PubMed ID: 35331933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nationwide effectiveness of five SARS-CoV-2 vaccines in Hungary-the HUN-VE study.
    Vokó Z; Kiss Z; Surján G; Surján O; Barcza Z; Pályi B; Formanek-Balku E; Molnár GA; Herczeg R; Gyenesei A; Miseta A; Kollár L; Wittmann I; Müller C; Kásler M
    Clin Microbiol Infect; 2022 Mar; 28(3):398-404. PubMed ID: 34838783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of the Comirnaty (BNT162b2, BioNTech/Pfizer) vaccine in preventing SARS-CoV-2 infection among healthcare workers, Treviso province, Veneto region, Italy, 27 December 2020 to 24 March 2021.
    Fabiani M; Ramigni M; Gobbetto V; Mateo-Urdiales A; Pezzotti P; Piovesan C
    Euro Surveill; 2021 Apr; 26(17):. PubMed ID: 33928898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to BNT162b2 mRNA COVID-19 vaccine among healthcare workers in Italy: a 3-month follow-up.
    Ponticelli D; Madotto F; Conti S; Antonazzo IC; Vitale A; Della Ragione G; Romano ML; Borrelli M; Schiavone B; Polosa R; Ferrara P; Mantovani LG
    Intern Emerg Med; 2022 Mar; 17(2):481-486. PubMed ID: 34637084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.